Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4 Study of Nilotinib in Korean Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase

NCT03332511 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT03332511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03332511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4 Study of Nilotinib in Korean Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
Lead sponsor
Seoul National University Hospital
Phase
Phase 4
Overall status
Completed
Start date
May 6, 2013
Completion date
October 24, 2016
Enrollment
110 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia, chronic phase